{"entity":{"type":"insider","cik":"0001706868","url":"/insider/0001706868","json_url":"/insider/0001706868.json","name":"KBL IV SPONSOR LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":4,"first":"2017-06-09","last":"2020-12-17","span_basis":"filed_date"},"name_variants":[{"name":"KBL IV SPONSOR LLC","source":"filing","n_filings":4,"first_seen":"2017-06-09","last_seen":"2020-12-17"}],"transactions":[{"id":3132703,"accession":"0001213900-20-043289","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001213900-20-043289","line_url":"/filing/0001213900-20-043289","is_derivative":false,"issuer_cik":"0001033308","issuer_name":"180 Life Sciences Corp.","issuer_ticker":"ATNF","issuer_name_source":null,"issuer_url":"/issuer/0001033308","owner_cik":null,"owner_name":"KBL IV SPONSOR LLC; KRAUSS MARLENE","owner_display_name":"KBL IV SPONSOR LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16506.0,"shares_display":"16,506","price_per_share":2.4766624257845633,"price_display":"2.48","price_state":"stated","total_value":40879.79,"total_display":"40,879.79","total_whole":"40,880","shares_owned_after":2006858.0,"shares_owned_after_display":"2,006,858","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-17","filed_date":"2020-12-17","scope":"insider","n_lines":2},{"id":3132690,"accession":"0001213900-20-043289","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-20-043289","line_url":"/filing/0001213900-20-043289#line-2","is_derivative":false,"issuer_cik":"0001033308","issuer_name":"180 Life Sciences Corp.","issuer_ticker":"ATNF","issuer_name_source":null,"issuer_url":"/issuer/0001033308","owner_cik":null,"owner_name":"KBL IV SPONSOR LLC; KRAUSS MARLENE","owner_display_name":"KBL IV SPONSOR LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17877.0,"shares_display":"17,877","price_per_share":2.4,"price_display":"2.40","price_state":"stated","total_value":42904.8,"total_display":"42,904.80","total_whole":"42,905","shares_owned_after":2543676.0,"shares_owned_after_display":"2,543,676","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-15","filed_date":"2020-12-17","scope":"insider"},{"id":3132680,"accession":"0001213900-20-043289","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-20-043289","line_url":"/filing/0001213900-20-043289#line-1","is_derivative":false,"issuer_cik":"0001033308","issuer_name":"180 Life Sciences Corp.","issuer_ticker":"ATNF","issuer_name_source":null,"issuer_url":"/issuer/0001033308","owner_cik":null,"owner_name":"KBL IV SPONSOR LLC; KRAUSS MARLENE","owner_display_name":"KBL IV SPONSOR LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":2.45,"price_display":"2.45","price_state":"stated","total_value":24500.0,"total_display":"24,500.00","total_whole":"24,500","shares_owned_after":2561553.0,"shares_owned_after_display":"2,561,553","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-14","filed_date":"2020-12-17","scope":"insider"},{"id":2799760,"accession":"0001213900-20-040310","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001213900-20-040310","line_url":"/filing/0001213900-20-040310#line-5","is_derivative":false,"issuer_cik":"0001033308","issuer_name":"180 Life Sciences Corp.","issuer_ticker":"ATNF","issuer_name_source":null,"issuer_url":"/issuer/0001033308","owner_cik":null,"owner_name":"KBL IV SPONSOR LLC; KRAUSS MARLENE","owner_display_name":"KBL IV SPONSOR LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12182.0,"shares_display":"12,182","price_per_share":2.7753,"price_display":"2.78","price_state":"stated","total_value":33808.7046,"total_display":"33,808.70","total_whole":"33,809","shares_owned_after":2571556.0,"shares_owned_after_display":"2,571,556","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-25","filed_date":"2020-12-01","scope":"insider"},{"id":2799754,"accession":"0001213900-20-040310","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001213900-20-040310","line_url":"/filing/0001213900-20-040310#line-4","is_derivative":false,"issuer_cik":"0001033308","issuer_name":"180 Life Sciences Corp.","issuer_ticker":"ATNF","issuer_name_source":null,"issuer_url":"/issuer/0001033308","owner_cik":null,"owner_name":"KBL IV SPONSOR LLC; KRAUSS MARLENE","owner_display_name":"KBL IV SPONSOR LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60633.0,"shares_display":"60,633","price_per_share":3.2602,"price_display":"3.26","price_state":"stated","total_value":197675.7066,"total_display":"197,675.71","total_whole":"197,676","shares_owned_after":2583738.0,"shares_owned_after_display":"2,583,738","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-23","filed_date":"2020-12-01","scope":"insider"},{"id":2799749,"accession":"0001213900-20-040310","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-20-040310","line_url":"/filing/0001213900-20-040310#line-3","is_derivative":false,"issuer_cik":"0001033308","issuer_name":"180 Life Sciences Corp.","issuer_ticker":"ATNF","issuer_name_source":null,"issuer_url":"/issuer/0001033308","owner_cik":null,"owner_name":"KBL IV SPONSOR LLC; KRAUSS MARLENE","owner_display_name":"KBL IV SPONSOR LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33445.0,"shares_display":"33,445","price_per_share":2.118,"price_display":"2.12","price_state":"stated","total_value":70836.51,"total_display":"70,836.51","total_whole":"70,837","shares_owned_after":2644371.0,"shares_owned_after_display":"2,644,371","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-19","filed_date":"2020-12-01","scope":"insider"},{"id":2799745,"accession":"0001213900-20-040310","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-20-040310","line_url":"/filing/0001213900-20-040310#line-2","is_derivative":false,"issuer_cik":"0001033308","issuer_name":"180 Life Sciences Corp.","issuer_ticker":"ATNF","issuer_name_source":null,"issuer_url":"/issuer/0001033308","owner_cik":null,"owner_name":"KBL IV SPONSOR LLC; KRAUSS MARLENE","owner_display_name":"KBL IV SPONSOR LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6700.0,"shares_display":"6,700","price_per_share":2.3105,"price_display":"2.31","price_state":"stated","total_value":15480.35,"total_display":"15,480.35","total_whole":"15,480","shares_owned_after":2677816.0,"shares_owned_after_display":"2,677,816","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-18","filed_date":"2020-12-01","scope":"insider"},{"id":2799739,"accession":"0001213900-20-040310","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-20-040310","line_url":"/filing/0001213900-20-040310#line-1","is_derivative":false,"issuer_cik":"0001033308","issuer_name":"180 Life Sciences Corp.","issuer_ticker":"ATNF","issuer_name_source":null,"issuer_url":"/issuer/0001033308","owner_cik":null,"owner_name":"KBL IV SPONSOR LLC; KRAUSS MARLENE","owner_display_name":"KBL IV SPONSOR LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":2.2562,"price_display":"2.26","price_state":"stated","total_value":7445.46,"total_display":"7,445.46","total_whole":"7,445","shares_owned_after":2684516.0,"shares_owned_after_display":"2,684,516","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-17","filed_date":"2020-12-01","scope":"insider"},{"id":4326728,"accession":"0001213900-17-006860","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-17-006860","line_url":"/filing/0001213900-17-006860#line-1","is_derivative":false,"issuer_cik":"0001033308","issuer_name":"KBL MERGER CORP. IV","issuer_ticker":"KBLMU","issuer_name_source":null,"issuer_url":"/issuer/0001033308","owner_cik":null,"owner_name":"KBL IV SPONSOR LLC; KRAUSS MARLENE","owner_display_name":"KBL IV SPONSOR LLC","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":27500.0,"shares_display":"27,500","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":275000.0,"total_display":"275,000.00","total_whole":"275,000","shares_owned_after":3252500.0,"shares_owned_after_display":"3,252,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-23","filed_date":"2017-06-27","scope":"insider"},{"id":5077484,"accession":"0001213900-17-006306","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-17-006306","line_url":"/filing/0001213900-17-006306#line-1","is_derivative":false,"issuer_cik":"0001033308","issuer_name":"KBL MERGER CORP. IV","issuer_ticker":"KBLMU","issuer_name_source":null,"issuer_url":"/issuer/0001033308","owner_cik":null,"owner_name":"KBL IV SPONSOR LLC; KRAUSS MARLENE","owner_display_name":"KBL IV SPONSOR LLC","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":350000.0,"shares_display":"350,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":3500000.0,"total_display":"3,500,000.00","total_whole":"3,500,000","shares_owned_after":3225000.0,"shares_owned_after_display":"3,225,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-07","filed_date":"2017-06-09","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001690080","name":"180 Life Sciences Corp.","url":"/issuer/0001690080","role":"Ten percent owner","n_filings":4,"first_seen":"2017-06-09","last_seen":"2020-12-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001706868","retrieved_at":"2026-08-25T16:14:07+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}